MONMOUTH JUNCTION, NJ–(Marketwired – July 16, 2015) – DiamiR Biosciences, a developer of innovative tests for detection and monitoring of neurodegenerative diseases, announced today that the company’s Chief Executive Officer, Dr. Kira Sheinerman, co-authored a poster presentation on behalf of the Alzheimer’s Association Small Company Consortium (AASCC). The poster focused on opportunities and challenges facing small companies targeting Alzheimer’s disease will be presented at the 2015 Alzheimer’s Association International Conference in Washington, DC.